China burdened with infectious diseases
This article was originally published in Clinica
Infectious diseases are a major cause of morbidity and death in China, claiming 1,000 lives in December 2007 and affecting 420,000 in total. According to China's Center for Disease Control and Prevention, the five most fatal diseases were: rabies; tuberculosis; AIDS; hepatitis B; and haemorrhagic fever. Infectious diseases, under China's law on the prevention and treatment of infectious diseases, are classified into three types: class A (plague and cholera); class B (25 diseases, including viral hepatitis, AIDS, TB, newborn tetanus and schistosomiasis or bilharzias); and class C (10 diseases, including influenza, Kala-azar or black fever and localised typhus). The class A and B infectious diseases of TB, hepatitis B, syphilis, diarrhoea and gonorrhoea were responsible for 86.65% of the overall incidence in December 2007.
You may also be interested in...
Emerging Company Profile: Axcella uses Generally Recognized As Safe (GRAS) amino acids to create drug candidates for hepatic encephalopathy, NASH and other diseases.
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.